Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Hung-Yao Lin, Tai-Chung Tseng

Clin Mol Hepatol. 2022;28(2):181-182. Published online February 21, 2022

DOI: https://doi.org/10.3350/cmh.2022.0028

View: 2303 Download: 92 Citation: 1

Jer-Wei Wu, Jia-Horng Kao, Tai-Chung Tseng

Clin Mol Hepatol. 2021;27(4):524-534. Published online February 23, 2021

DOI: https://doi.org/10.3350/cmh.2021.0012

View: 11337 Download: 315 Citations: 19

Tai-Chung Tseng

Clin Mol Hepatol. 2021;27(2):281-282. Published online March 10, 2021

DOI: https://doi.org/10.3350/cmh.2021.0072

View: 2687 Download: 95 Citations: 4

1 |

Viewed By 4126	Hepatocellular carcinoma surveillance in patients with non-alcoholic fatty liver disease
Viewed By 2723	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis
Viewed By 2445	The independent effect of exercise on biopsy proven non-alcoholic fatty liver disease: A systematic review
Viewed By 2438	Management of refractory ascites
Viewed By 2436	Recent updates on the management of autoimmune hepatitis

Cited By 99	KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
Cited By 43	From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?
Cited By 42	Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis
Cited By 40	Obesity and the risk of primary liver cancer: A systematic review and meta-analysis
Cited By 38	The development of mesenchymal stem cell therapy in the present, and the perspective of cell-free therapy in the future

Search